[1]
Samaa AbdAlla Bardisi et al. 2023. Body mass index as a prognostic factor in HER-2 positive early breast cancer patients and its effect on duration of treatment with Trastuzumab: A retrospective study. Journal of the Pakistan Medical Association. 73, 4 (May 2023), S257-S262. DOI:https://doi.org/10.47391/JPMA.EGY-S4-51.